24 May 2013
Keywords: phoqus, initiates, ph, ii, nih, chronocort, study
Article | 10 September 2007
UK drug developer Phoqus has initiated a Phase II clinical trial at the US National Institutes of Health of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 September 2007
23 May 2013
© 2013 thepharmaletter.com